Mangoceuticals, Inc. SEC filings MGRX

Mangoceuticals, Inc. has 240 filings in SEC EDGAR's recent list, going back to Aug 31, 2022. Its latest annual report, Form 10-K, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (material agreement). The company's fiscal year ends on December 31.

Mangoceuticals, Inc. SEC filings
Form Description Filed Period
425 Filing Aug 13, 2026 —
425 Filing Aug 6, 2026 —
425 Filing Aug 4, 2026 —
425 Filing Jul 30, 2026 —
425 Filing Jul 30, 2026 —
NT 10-Q Filing May 15, 2026 Mar 31, 2026
NT 10-K Filing Mar 31, 2026 Dec 31, 2025
EFFECT Filing Jan 28, 2026 —
UPLOAD Letter from the SEC Jan 27, 2026 —
CORRESP Letter to the SEC Jan 26, 2026 —
EFFECT Filing Jun 24, 2025 —
CORRESP Letter to the SEC Jun 20, 2025 —
UPLOAD Letter from the SEC Jun 20, 2025 —
EFFECT Filing Jun 18, 2025 —
CORRESP Letter to the SEC Jun 17, 2025 —
UPLOAD Letter from the SEC Jun 6, 2025 —
EFFECT Filing Sep 5, 2024 —
CORRESP Letter to the SEC Sep 3, 2024 —
AW Filing Aug 30, 2024 —
UPLOAD Letter from the SEC Aug 29, 2024 —
EFFECT Filing May 9, 2024 —
CORRESP Letter to the SEC May 7, 2024 —
UPLOAD Letter from the SEC Apr 30, 2024 —
EFFECT Filing Dec 19, 2023 —
EFFECT Filing Dec 14, 2023 —
CORRESP Letter to the SEC Dec 11, 2023 —
CORRESP Letter to the SEC Dec 11, 2023 —
CORRESP Letter to the SEC Dec 11, 2023 —
CORRESP Letter to the SEC Dec 11, 2023 —
UPLOAD Letter from the SEC Nov 30, 2023 —
DRS Filing Nov 24, 2023 —
SEC STAFF LETTER Filing Mar 29, 2023 —
CERT Filing Mar 21, 2023 —
EFFECT Filing Mar 20, 2023 —
CORRESP Letter to the SEC Mar 17, 2023 —
CORRESP Letter to the SEC Mar 17, 2023 —
CORRESP Letter to the SEC Mar 17, 2023 —
CORRESP Letter to the SEC Mar 17, 2023 —
CORRESP Letter to the SEC Mar 14, 2023 —
CORRESP Letter to the SEC Mar 14, 2023 —
CORRESP Letter to the SEC Feb 28, 2023 —
UPLOAD Letter from the SEC Feb 24, 2023 —
CORRESP Letter to the SEC Feb 22, 2023 —
CORRESP Letter to the SEC Feb 22, 2023 —
CORRESP Letter to the SEC Feb 10, 2023 —
CORRESP Letter to the SEC Feb 10, 2023 —
8-A12B Filing Feb 6, 2023 —
CORRESP Letter to the SEC Feb 3, 2023 —
UPLOAD Letter from the SEC Feb 1, 2023 —
SEC STAFF LETTER Filing Jan 24, 2023 —
DRSLTR Filing Dec 22, 2022 —
DRS/A Filing Dec 21, 2022 —
DRSLTR Filing Dec 20, 2022 —
UPLOAD Letter from the SEC Dec 9, 2022 —
DRS/A Filing Nov 18, 2022 —
DRSLTR Filing Nov 17, 2022 —
UPLOAD Letter from the SEC Oct 27, 2022 —
D/A Filing Oct 11, 2022 —
DRS Filing Sep 26, 2022 —
D Filing Aug 31, 2022 —

Showing 60 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Misc Health & Allied Services, NEC (SIC 8090)
Listed as
MGRX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
TX
Headquarters
Dallas, TX
SEC filer status
, Emerging growth company
SEC CIK
1938046
Former names
MANGOCEUTICALS, INC. (until Oct 9, 2026)

Other Services-Misc Health & Allied Services, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.